Physiomics (GB:PYC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Physiomics PLC, a key player in mathematical modelling for therapeutic development, has announced that Dr Christophe Chassagnole will resign as Director and Chief Scientific Officer on May 31, 2024, to explore new career opportunities. He leaves behind a legacy of contributions to the company’s services and intellectual property, with a consulting agreement in place to ensure his expertise remains accessible to Physiomics. The company has also entered into an IP Licensing Agreement with Dr Chassagnole, providing it with a royalty on sales derived from licensed software and models.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.